These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2862296)

  • 1. [Intrinsic sympathomimetic activity of beta-adrenoceptor blocking agents--effects on hemodynamics].
    Miyazaki M; Mitsufuji T; Yokono S
    Masui; 1985 Mar; 34(3):272-9. PubMed ID: 2862296
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta blockers with intrinsic sympathomimetic activity.
    White WB
    Am Fam Physician; 1985 Jan; 31(1):115-8. PubMed ID: 2857059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of beta-adrenoceptor blocking agents on hemodynamic variables and on baroreceptor and postganglionic sympathetic activities in rabbits.
    Chevalier-Cholat AM; Friggi A; Torresani J
    Biomedicine; 1978; 28(1):67-72. PubMed ID: 27257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta blocking agents and arterial hypertension].
    Squadrito G
    G Clin Med; 1979 May; 60(5):347-65. PubMed ID: 39861
    [No Abstract]   [Full Text] [Related]  

  • 5. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
    Svendsen TL
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological studies on the intrinsic sympathomimetic activity of the beta-adrenoceptor antagonist mepindolol.
    Beckmann R; Müller B; Schröder G; Stock G
    Arzneimittelforschung; 1986 May; 36(5):811-3. PubMed ID: 2873820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodynamic effects of intravenous beta-blocking drugs in coronary heart disease.
    Taylor SH; Silke B; Nelson GI
    J Pharmacol; 1983; 14 Suppl 2():157-67. PubMed ID: 6138465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-adrenoceptor blockade and intrinsic sympathomimetic activity--relevance in the treatment of ischaemic heart disease.
    Northcote RJ; Ballantyne D
    Scott Med J; 1985 Oct; 30(4):208-15. PubMed ID: 2869581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blocking of beta-adrenoceptors in arterial hypertension].
    Aramendia P
    Medicina (B Aires); 1980; 40(4):467-77. PubMed ID: 6111016
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta adrenergic blocking agents for exertional angina pectoris.
    Thadani U
    Herz; 1982 Jun; 7(3):179-87. PubMed ID: 6124493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some haemodynamic effects of LB 46 (Visken).
    Smyth AJ; Watson O; Peel JS; Turner AS
    N Z Med J; 1970 Oct; 72(461):246-7. PubMed ID: 4395124
    [No Abstract]   [Full Text] [Related]  

  • 13. Haemodynamic and baroreceptor responses to beta-adrenoceptor blocking agents in rabbits with cardiopulmonary bypass.
    Friggi A; Chevalier-Cholat AM; Torresani J
    Eur J Pharmacol; 1977 Oct; 45(3):295-300. PubMed ID: 21801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multidimensional concept for measuring CNS effects of beta-adrenoceptor blocking agents in human pharmacology.
    Wagner W; Ott H; Herrmann WM; McDonald RJ; Berzewski B
    Int J Clin Pharmacol Ther Toxicol; 1981 Jan; 19(1):23-33. PubMed ID: 6110635
    [No Abstract]   [Full Text] [Related]  

  • 15. How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.
    Man in 't Veld AJ; Schalekamp MA
    Br J Clin Pharmacol; 1982; 13(Suppl 2):245S-257S. PubMed ID: 6125175
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulation of functional capacity and survival in congestive heart failure. Effects of activation of the sympathetic nervous system.
    Packer M
    Postgrad Med; 1988 Feb; Spec No():96-103. PubMed ID: 2894667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blocking and hemodynamic effects of ASL-8052.
    Gorczynski RJ; Murthy VS; Hwang TF
    J Cardiovasc Pharmacol; 1984; 6(6):1548-59. PubMed ID: 6084788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha and beta adrenoceptor blocking properties of labetalol and its R,R-isomer, SCH 19927.
    Sybertz EJ; Sabin CS; Pula KK; Vliet GV; Glennon J; Gold EH; Baum T
    J Pharmacol Exp Ther; 1981 Aug; 218(2):435-43. PubMed ID: 6114171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of YM-16151-4: a novel calcium entry blocking and selective beta 1-adrenoceptor blocking agent in rats and dogs.
    Uchida W; Shibasaki K; Matsuda Y; Asano M; Takenaka T
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):247-52. PubMed ID: 7692165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.